Views from the boardroom
(China daily) Updated: 2015-09-24 08:58
Wu Xiaobin, president of Pfizer Investment China: From a pharmaceutical industry perspective, we hope the Chinese government will further implement policies that support and encourage biopharmaceutical innovation, accelerate the approval process of new medicines, and enhance the quality of domestic generics to the international level. More
Huang Chenhong, president, Dell Greater China: China is already a competitive market, and very open. We'll just have to make ourselves more excellent in execution and enhance our competitiveness, and offer better solutions, bringing value to society and our customers. More
- Views from the boardroom
- Chinese president reassures US business leaders on economy
- Leaders target ongoing bureaucratic inaction
- Transforming the pork market
- Business sentiment among Japanese companies in China improves
- Gree chief sets sights on smart-home appliances
- CNOOC forms new venture with private-sector partner
- Tech talk to help with China-US discussions
Hot Topics
Editor's Picks
